Literature DB >> 6509398

The natural history of Machado-Joseph disease. An analysis of 138 personally examined cases.

A Barbeau, M Roy, L Cunha, A N de Vincente, R N Rosenberg, W L Nyhan, P L MacLeod, G Chazot, L B Langston, D M Dawson.   

Abstract

We have examined 138 cases of a disorder previously described in people of Portuguese origin and which has received many names. By computer analysis of 46 different items of a standardized neurological examination carried out in each patient, we have been able to delineate the main components of the clinical presentation, to conclude that the marked variability in clinical expressions does not negate the homogeneity of the disorder, and to describe the natural history of this entity which should be called, for historical reasons, "Machado-Joseph Disease". This hereditary disease has an autosomal dominant pattern of inheritance, presenting as a progressive ataxia with external ophthalmoplegia, and should be classified within the group of "Ataxic multisystem degenerations". When the disease starts before the age of 20, it may present with marked spasticity, of a non progressive nature but often so severe that it can be accompanied by "Gegenhalten" countermovements and dystonic postures but little frank dystonia. There are few true extrapyramidal symptoms except akinesia. When the disease starts after the age of 50, the clinical spectrum is mostly that of an amyotrophic polyneuropathy with fasciculations accompanying the ataxia. For all the other cases the clinical picture is a continuum between these two extremes, the main determinant of the clinical phenotype being the age of onset and a secondary factor, the place of origin of the given kindred. The ataxic and amyotrophic components are clearly progressive with time in contrast to the spasticity component. Although the majority of known cases are of Portuguese origin, this is not obligatory. The next research endeavour should be a search for the chromosomal site of the gene, using molecular biology technology such as those for recombinant DNA.

Entities:  

Mesh:

Year:  1984        PMID: 6509398     DOI: 10.1017/s0317167100034983

Source DB:  PubMed          Journal:  Can J Neurol Sci        ISSN: 0317-1671            Impact factor:   2.104


  11 in total

1.  Characterisation of the unstable expanded CAG repeat in the MJD1 gene in four Brazilian families of Portuguese descent with Machado-Joseph disease.

Authors:  G Stevanin; E Cassa; G Cancel; N Abbas; A Dürr; E Jardim; Y Agid; P S Sousa; A Brice
Journal:  J Med Genet       Date:  1995-10       Impact factor: 6.318

2.  Spinocerebellar ataxia type 3/Machado-Joseph disease starting before adolescence.

Authors:  Karina Carvalho Donis; Jonas Alex Morales Saute; Ana Carolina Krum-Santos; Gabriel Vasata Furtado; Eduardo Preusser Mattos; Maria Luiza Saraiva-Pereira; Vanessa Leotti Torman; Laura Bannach Jardim
Journal:  Neurogenetics       Date:  2016-01-16       Impact factor: 2.660

Review 3.  Mouse models of spinocerebellar ataxia type 3 (Machado-Joseph disease).

Authors:  Veronica F Colomer Gould
Journal:  Neurotherapeutics       Date:  2012-04       Impact factor: 7.620

4.  Relations between genotype and phenotype in German patients with the Machado-Joseph disease mutation.

Authors:  L Schöls; G Amoiridis; J T Epplen; M Langkafel; H Przuntek; O Riess
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-11       Impact factor: 10.154

5.  Delirium associated with Joseph disease.

Authors:  Y Fukutani; K Katsukawa; R Matsubara; K Kobayashi; I Nakamura; N Yamaguchi
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-11       Impact factor: 10.154

6.  Machado Joseph disease maps to the same region of chromosome 14 as the spinocerebellar ataxia type 3 locus.

Authors:  E C Twist; L K Casaubon; M H Ruttledge; V S Rao; P M Macleod; J Radvany; Z Zhao; R N Rosenberg; L A Farrer; G A Rouleau
Journal:  J Med Genet       Date:  1995-01       Impact factor: 6.318

7.  Machado-Joseph disease in pedigrees of Azorean descent is linked to chromosome 14.

Authors:  P St George-Hyslop; E Rogaeva; J Huterer; T Tsuda; J Santos; J L Haines; K Schlumpf; E I Rogaev; Y Liang; D R McLachlan
Journal:  Am J Hum Genet       Date:  1994-07       Impact factor: 11.025

8.  Machado Joseph disease is not an allele of the spinocerebellar ataxia 2 locus.

Authors:  E C Twist; L A Farrer; P M Macleod; J Radvany; S Chamberlain; R N Rosenberg; G A Rouleau
Journal:  Hum Genet       Date:  1994-03       Impact factor: 4.132

9.  Spinocerebellar ataxia type 1 and Machado-Joseph disease: incidence of CAG expansions among adult-onset ataxia patients from 311 families with dominant, recessive, or sporadic ataxia.

Authors:  L P Ranum; J K Lundgren; L J Schut; M J Ahrens; S Perlman; J Aita; T D Bird; C Gomez; H T Orr
Journal:  Am J Hum Genet       Date:  1995-09       Impact factor: 11.025

10.  Limited Effect of Chronic Valproic Acid Treatment in a Mouse Model of Machado-Joseph Disease.

Authors:  Sofia Esteves; Sara Duarte-Silva; Luana Naia; Andreia Neves-Carvalho; Andreia Teixeira-Castro; Ana Cristina Rego; Anabela Silva-Fernandes; Patrícia Maciel
Journal:  PLoS One       Date:  2015-10-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.